Island Pharmaceuticals LtdASX: ILA

Investor presentation

· Issued by Island Pharmaceuticals Ltd via ASX

Filed with ASX ·

COMBATTING URGENT VIRAL DISEASE THREATS Dual Approach to Advance Galidesivir as a Pan - Filovirus Medical Countermeasure BioShares 2026 Dr David Foster, CEO & Managing Director August 7, 2026 ASX: ILA Cumulative Ebola cases in past outbreaks 01 Island Pharmaceuticals Limited Days since...

View Attachment

6ix hasn’t read this filing yet.

Island Pharmaceuticals Ltd on 6ix

In the deck

Earlier from Island Pharmaceuticals

Later from Island Pharmaceuticals

All Island Pharmaceuticals news releases